Nephros Future Growth
Future criteria checks 4/6
Nephros is forecast to grow earnings and revenue by 128.2% and 10.1% per annum respectively while EPS is expected to grow by 122.8% per annum.
Key information
128.2%
Earnings growth rate
122.8%
EPS growth rate
Machinery earnings growth | 9.5% |
Revenue growth rate | 10.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)
Oct 03We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn
Jul 14Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates
May 13After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar
Dec 18At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?
Dec 14Nephros partners with Donastar and Tractor Beverage to supply and service nationwide fast-casual restaurant operation
Sep 28US$5.13: That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After Its Latest Results
Aug 13Market Sentiment Around Loss-Making Nephros, Inc. (NASDAQ:NEPH)
Mar 25At US$8.37, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?
Mar 04Announcing: Nephros (NASDAQ:NEPH) Stock Increased An Energizing 131% In The Last Five Years
Jan 28Nephros sees Q4 revenue in-line with estimates,
Jan 12Nephros, Inc. (NASDAQ:NEPH) Insiders Increased Their Holdings
Dec 08Nephros EPS beats by $0.02, misses on revenue
Nov 05Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 17 | 1 | N/A | N/A | 1 |
12/31/2025 | 15 | 0 | N/A | N/A | 1 |
12/31/2024 | 14 | 0 | N/A | N/A | 2 |
9/30/2024 | 14 | -1 | -2 | -2 | N/A |
6/30/2024 | 14 | -1 | -1 | -1 | N/A |
3/31/2024 | 14 | -1 | 0 | 0 | N/A |
12/31/2023 | 14 | -2 | 1 | 1 | N/A |
9/30/2023 | 14 | -2 | 1 | 1 | N/A |
6/30/2023 | 12 | -3 | 0 | 0 | N/A |
3/31/2023 | 12 | -3 | -1 | -1 | N/A |
12/31/2022 | 10 | -5 | -3 | -3 | N/A |
9/30/2022 | 10 | -5 | -4 | -3 | N/A |
6/30/2022 | 10 | -4 | -4 | -4 | N/A |
3/31/2022 | 10 | -4 | -3 | -3 | N/A |
12/31/2021 | 10 | -3 | -2 | -1 | N/A |
9/30/2021 | 10 | -3 | -3 | -3 | N/A |
6/30/2021 | 9 | -4 | -4 | -4 | N/A |
3/31/2021 | 9 | -4 | -5 | -5 | N/A |
12/31/2020 | 9 | -5 | -7 | -7 | N/A |
9/30/2020 | 9 | -4 | -5 | -5 | N/A |
6/30/2020 | 10 | -4 | -4 | -4 | N/A |
3/31/2020 | 11 | -3 | -3 | -3 | N/A |
12/31/2019 | 10 | -3 | -2 | -2 | N/A |
9/30/2019 | 9 | -4 | -3 | -3 | N/A |
6/30/2019 | 7 | -4 | -4 | -4 | N/A |
3/31/2019 | 6 | -3 | -4 | -4 | N/A |
12/31/2018 | 6 | -3 | -4 | -4 | N/A |
9/30/2018 | 5 | -1 | -1 | -1 | N/A |
6/30/2018 | 5 | -1 | N/A | -1 | N/A |
3/31/2018 | 4 | -2 | N/A | 0 | N/A |
12/31/2017 | 4 | -1 | N/A | 0 | N/A |
9/30/2017 | 3 | -3 | N/A | -2 | N/A |
6/30/2017 | 3 | -3 | N/A | -2 | N/A |
3/31/2017 | 2 | -3 | N/A | -2 | N/A |
12/31/2016 | 2 | -3 | N/A | -2 | N/A |
9/30/2016 | 2 | -3 | N/A | -3 | N/A |
6/30/2016 | 2 | -3 | N/A | -3 | N/A |
3/31/2016 | 2 | -4 | N/A | -3 | N/A |
12/31/2015 | 2 | -3 | N/A | -4 | N/A |
9/30/2015 | 2 | -3 | N/A | -3 | N/A |
6/30/2015 | 2 | 0 | N/A | -3 | N/A |
3/31/2015 | 2 | -4 | N/A | -3 | N/A |
12/31/2014 | 2 | -7 | N/A | -2 | N/A |
9/30/2014 | 2 | -2 | N/A | -3 | N/A |
6/30/2014 | 2 | -6 | N/A | -2 | N/A |
3/31/2014 | 2 | -1 | N/A | -3 | N/A |
12/31/2013 | 2 | 1 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NEPH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: NEPH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: NEPH is expected to become profitable in the next 3 years.
Revenue vs Market: NEPH's revenue (10.1% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: NEPH's revenue (10.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NEPH's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 18:06 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nephros, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Wasserman | Benchmark Company |
Marc Wiesenberger | B. Riley Securities, Inc. |
Anthony Vendetti | Maxim Group |